Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124740802 | 12474080 | 2 | F | 20160510 | 20160722 | 20160616 | 20160810 | PER | US-009507513-1606USA000403 | MERCK | 61.96 | YR | F | Y | 85.71000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124740802 | 12474080 | 1 | PS | JANUMET XR | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | STRENGTH: 100/1000 (UNSPECIFIED UNITS) AND DOSAGE: ONE 100/1000 (UNSPECIFIED UNITS) TABLET DAILY | Y | 22044 | 1 | DF | PROLONGED-RELEASE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124740802 | 12474080 | 1 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124740802 | 12474080 | Abdominal pain | |
| 124740802 | 12474080 | Diarrhoea | |
| 124740802 | 12474080 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124740802 | 12474080 | 1 | 20160510 | 201605 | 0 |